Timothy John Garnett's most recent trade in MapLight Therapeutics Inc. was a trade of 14,902 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 23, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MapLight Therapeutics Inc | Timothy John Garnett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2026 | 14,902 | 14,902 | - | - | Stock Option (right to buy) | |
| MapLight Therapeutics Inc | Timothy John Garnett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2026 | 3,932 | 53,457 | - | 0 | Voting Common Stock | |
| MapLight Therapeutics Inc | Timothy John Garnett | Director | Purchase of securities on an exchange or from another person at price $ 17.89 per share. | 10 Feb 2026 | 14,124 | 14,124 | - | 17.9 | 252,678 | Voting Common Stock |
| MapLight Therapeutics Inc | Timothy John Garnett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 25,604 | 25,604 | - | - | Employee Stock Option (right to buy) | |
| MapLight Therapeutics Inc | Timothy John Garnett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2025 | 6,294 | 6,294 | - | 0 | Voting Common Stock |